Targeted prostate cancer treatment cuts risk of side effects, study suggests
An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.
A recent study suggests that a targeted treatment for prostate cancer may significantly reduce the risk of side effects associated with traditional treatments. The 10-year NHS trial, which followed nearly 3,500 men, used focal therapy, a less invasive approach that targets only the affected areas of the prostate. This is a promising development for men diagnosed with prostate cancer, as it may allow them to avoid more severe side effects such as incontinence and impotence.
The use of focal therapy is a growing trend in prostate cancer treatment, as it offers a more precise and less damaging alternative to traditional treatments like surgery or radiotherapy. By targeting only the affected areas, focal therapy aims to minimize damage to healthy tissue and reduce the risk of side effects. This approach has been gaining traction in recent years, with several studies suggesting its effectiveness in treating prostate cancer.
As the study's findings are further analyzed and validated, men with prostate cancer may have a new treatment option to consider. What's next to watch is how focal therapy will be integrated into mainstream treatment protocols and whether it will become a standard treatment option for prostate cancer patients. Additionally, further research is needed to determine the long-term effectiveness of focal therapy and its potential applications in treating other types of cancer.
Originally reported by bbc.co.uk. MyNews adds analysis for general news readers.